Search

When treating heart attacks, should doctors unblock all blocked arteries or just the main culprit? BHF-funded research helped answer that question.

We will work with supporters, volunteers and partners to inspire the support and income we need to power lifesaving progress into heart and circulatory disease.

Over the next 5 year, we’re working with Toolstation to help protect the hearts of the nation and Toolstation communities.

The Healthcare Implementation Fund Committee meets twice a year to assess grant applications for innovative projects that aim to improve service delivery for people with cardiovascular disease.

Hypertrophic cardiomyopathy is an inherited disease of the heart muscle. BHF-funded research helped identify the faulty genes causing the conditions and we’ve helped make genetic testing available to the families affected.

The weight loss jab Wegovy will soon be prescribed on the NHS to over 1 million people with cardiovascular disease to help prevent them from having a deadly heart attack or stroke, the health service has announced.

Covid-19 can cause serious illness if you have a heart or circulatory disease. Find out who’s at risk of serious illness, what to do if you test positive and how to manage symptoms.

We're excited to support a new $55m global research programme called VISIBLE from Wellcome Leap - jointly funded by Pivotal - to improve women's heart health.

The team behind the CvLPRIT trial wanted to find out if all narrowed vessels should be reopened during angioplasty to treat a heart attack.